Analysis summary
CRM screens neutral with a 5/100 direction score. Bullish evidence includes Max Pain sits above spot, suggesting upward expiry pin pressure; Gamma wall is described as nearby put-side support. Bearish evidence includes AI prediction leans down at 42.5% probability up; 25-delta risk reversal is put-heavy at -4.1 vol pts.